Startup profile · funding coverage
Warp Sciences funding, valuation and investors
US chemistry research services combining chemists, AI and robotics for biotech and pharma.
Verified company research · funding, investors and latest developments
Keep track of Warp Sciences
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Series A
$215M · October 22, 2026
Latest known valuation
$865M post-money, reported by Bloomberg citing the company
Series A · October 22, 2026
Total disclosed equity funding
$215M
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
series a
Investors in latest funding
Lead: Lightspeed Venture Partners
Other: Premji Invest , Mayfield , IVP , Lux Capital , Conviction , Menlo Ventures , 01 Advisors , Standard , Lowercarbon Capital , Gigascale Capital , Angular Ventures , Scribble Ventures , Uncork Capital , Innovation Endeavors , Matter VP , Zero Shot Fund , SignalFire , Moxxie Ventures
Overview
Warp Sciences is building a US-based chemistry contract research organization. Its initial service makes variations of molecules for lead optimization. The company announced $215M on October 22, 2026; lead investor Lightspeed identifies the financing as a Series A. Bloomberg reported an $865M post-money valuation, citing the company. Prices, revenue and named customers were not disclosed in the launch announcement.
Why Warp Sciences is interesting
Warp is building laboratory infrastructure for customer-owned drug programs rather than its own proprietary drug pipeline.
Funding history (newest first)
Series A
2026-10-22 $215M Valuation: $865M post-money, reported by Bloomberg citing the company- Lightspeed Venture Partners (lead)
- Premji Invest (participant)
- Mayfield (participant)
- IVP (participant)
- Lux Capital (participant)
- Conviction (participant)
- Menlo Ventures (participant)
- 01 Advisors (participant)
- Standard (participant)
- Lowercarbon Capital (participant)
- Gigascale Capital (participant)
- Angular Ventures (participant)
- Scribble Ventures (participant)
- Uncork Capital (participant)
- Innovation Endeavors (participant)
- Matter VP (participant)
- Zero Shot Fund (participant)
- SignalFire (participant)
- Moxxie Ventures (participant)
Investors in our directory
Funds linked from Warp Sciences's profile — open a fund page for stage focus and related deal articles.
Competitive landscape
-
Chemify direct
Automates molecule synthesis for pharma, biotech and materials customers.
-
Lila Sciences adjacent
Broader AI laboratory platform across life science, chemistry and materials.
Industries
Market / IPO context
Editorial / static context — not a live quote.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.